Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28839149 | 1.00 | TDP1 (0.53) | TDP1POLBMAPK1ABCB1 | |
| SCHEMBL14661288 | 1.00 | TDP1 (0.53) | TDP1POLBMAPK1ABCB1 | |
| SCHEMBL14661031 | 1.00 | TDP1 (0.53) | TDP1POLBMAPK1ABCB1 | |
| SCHEMBL9775304 | 0.92 | TDP1 (0.49) | TDP1POLBMAPK1ABCB1 | |
| SCHEMBL13893402 | 0.86 | TDP1 (0.71) | TDP1POLBMAPK1ABCB1 | |
| SCHEMBL29529175 | 0.86 | TDP1 (0.71) | TDP1POLBMAPK1ABCB1 | |
| SCHEMBL60713 | 0.86 | TDP1 (0.71) | TDP1POLBMAPK1ABCB1 | |
| SCHEMBL15653578 | 0.86 | TDP1 (0.71) | TDP1POLBMAPK1ABCB1 | |
| SCHEMBL426635 | 0.86 | TDP1 (0.71) | TDP1POLBMAPK1ABCB1 | |
| SCHEMBL421756 | 0.86 | TDP1 (0.71) | TDP1POLBMAPK1ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220025185-A1 | SPECIFICALLY GLYCO-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PHOTODYNAMIC THERAPY | UNIVERSITAT HAMBURG (DE) | 2022-01-27 | — | — | US | disclosed |
| EP-3894421-A1 | SPECIFICALLY GLYCO-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PHOTODYNAMIC THERAPY | Universität Hamburg (DE) | 2021-10-20 | — | — | EP | disclosed |
| WO-2020120474-A1 | SPECIFICALLY GLYCO-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PHOTODYNAMIC THERAPY | UNIVERSITÄT HAMBURG (DE) | 2020-06-18 | — | — | WO | disclosed |
| EP-2616065-B1 | GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND B-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY | BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG (AT) | 2017-11-01 | — | — | EP | disclosed |
| US-9308185-B2 | Glyco-substituted dihydroxy-chlorins and β-functionalized chlorins for anti-microbial photodynamic therapy | BIOLITEC PHARMA MARKETING LTD (MY) | 2016-04-12 | — | — | US | disclosed |
| EP-2616065-A1 | GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND B-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY | Biolitec Pharma Marketing Ltd (MY) | 2013-07-24 | — | — | EP | disclosed |
| WO-2013015774-A1 | GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND B-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY | BIOLITEC PHARMA MARKETING LTD (MY) | 2013-01-31 | — | — | WO | disclosed |
| US-20090206245-A1 | Mass analysis method using fine metal particles | SHIONOGI CO., LTD (JP) | 2009-08-20 | — | — | US | disclosed |
| EP-1731905-A1 | MASS ANALYSIS METHOD USING FINE METAL PARTICLES | Shionogi Co., Ltd. (JP) | 2006-12-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090206245-A1 | Mass analysis method using fine metal particles | OSTC, ZKSCAN2, SLC17A5 | TDP1 4456/4885POLB 2545/4885MAPK1 3007/4885 |
| US-20220025185-A1 | SPECIFICALLY GLYCO-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PHOTODYNAMIC THERAPY | B3GAT3, ST6GAL1, ST3GAL3 | TDP1 1747/4885POLB 2644/4885MAPK1 3581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.